NCPH is a heterogeneous group of liver disorders of vascular origin, leading to PHT with
near normal HVPG. NCPF/IPH is a disorder of young adults or middle aged women …

Non-selective beta-blockers (NSBBs) are the mainstay of treatment for portal hypertension in
the setting of liver cirrhosis. Randomised controlled trials demonstrated their efficacy in …

This Practice Guidance from the American Association for the Study of Liver Disease
(AASLD) intends to coalesce best practice recommendations for the identification of portal …

Gastroesophageal varices are present at diagnosis in almost half of patients with cirrhosis,
and variceal hemorrhage continues to be a lethal complication of cirrhosis. This review …

Extrahepatic portal vein obstruction (EHPVO) is an important cause of noncirrhotic portal
hypertension, especially in Third World countries. The etiology and clinical presentation are …

Bleeding from esophageal varices is a life threatening complication of portal hypertension.
Primary prevention of bleeding in patients at risk for a first bleeding episode is therefore a …

AIM: To describe the pathophysiology, clinical presentation, natural history, and therapy of
portal hypertensive gastropathy (PHG) based on a systematic literature review. METHODS …

The diagnosis of PHG is made endoscopically. The New Italian Endoscopic Club has
classified the severity of PHG based on the presence of four elementary lesions: mosaiclike …

Background Idiopathic portal hypertension (IPH) and extrahepatic portal venous obstruction
(EHPVO) are non-cirrhotic vascular causes of portal hypertension (PHT). Variceal bleed and …

Abstract The Asian Pacific Association for the Study of the Liver (APASL) Working Party on
Portal Hypertension has developed consensus guidelines on the disease profile, diagnosis …